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Although laparoscopic adhesiolysis for adhesive small bowel obstruction are being undertaken 
more frequently, widespread acceptance is lacking because supporting evidence is limited and 
there is a concern regarding its benefits. 
 
Methods 
In an international, multicenter, parallel, open-label trial, we randomly assigned 104 patients who 
had adhesive small bowel obstruction not resolving by conservative means to undergo either open 
or laparoscopic adhesiolysis (allocation ratio 1:1) using sealed envelope method between July 
2013 and April 2018. The study was conducted in five academic university and three community 
(central) hospitals in two countries (Finland and Italy). We designed key exclusion criteria to 
include only patients with high likelihood of single adhesive band into the trial. The primary 
outcome was postoperative length of stay assessed at time of discharge. Key secondary outcomes 
were complications within 30 days, return of bowel function during the hospital stay, 
postoperative pain within 7 postoperative days, length of epidural catheter during the hospital 
stay, use of opioids during the hospital stay, and length of sick leave (assessed at the end of the 
sick leave). This trial was registered with ClinicalTrials.gov, number NCT01867528. 
 
Findings 
One hundred patients were included in the modified intention-to-treat analyses (49 in the open 
surgery group and 51 in the laparoscopy group). The postoperative length of stay for open group 
was on average 1·3 days longer than that in laparoscopy group (geometric mean 5·5 (range 2 – 19) 
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versus 4·2 (range 1 - 20), ratio of geometric means 1·31 (95% confidence interval 1·06 – 1·61), p = 
0·013). The rate of complications (21 (43%) vs. 16 (31%), p = 0·23, OR 0·61 (95% CI 0·27 – 1·38)) 
was similar between open and laparoscopic groups, respectively. Time from surgery to bowel 
function was shorter in laparoscopy group (geometric mean 41 hours) than in open group 
(geometric mean 63 hours) (ratio of geometric means 1·54 (95% CI 1·11 – 2·11), p = 0·007). Pain 
was lower in laparoscopy group on day 3 (median of daily mean pain of visual analog scale 2 (IQR 1 
– 3) versus median 1 (IQR 0 – 2), p = 0.006, r = 0.32) and day 4 (median 1.5 (IQR 0·5 – 3) versus 0·5 
(IQR 0 – 1·5), p = 0·015, r = 0·32) compared to open group, respectively. The length of epidural 
catheter was longer in open group than in laparoscopy group (median 39 hours (IQR 0 – 54) versus 
median 0 hours (IQR 0 – 0), p < 0·001, r = 0·51). Opioid use was similar between the groups 
(median milligrams of morphine equivalent per day 5·7 (IQR 1·0 – 12·0) in open group versus 3·6 
(IQR 0 – 12·2) in laparoscopy group, p = 0·47, r = 0·07). The length of sick leave was on average 12 
days longer in open group than in laparoscopy group (geometric means 24 days (n = 10) versus 12 
days (n = 11), ratio of geometric means 1·90 (1·03 – 3·51), p = 0.04). One patient died in both 
group within 30 days. Surgery in 13 patients (25%) in laparoscopic group were converted to open 
surgery. 
Interpretation 
Laparoscopic adhesiolysis provides quicker recovery in selected patients with adhesive small 
bowel obstruction.  
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Small bowel obstruction is a common surgical emergency, and adhesions are the most common 
cause.1,2 While (suspicion of) strangulation requires immediate operative treatment, initial 
management of non-strangulated adhesive small bowel obstruction consists of non-operative 
treatment by decompressing the bowel, restoring fluid balance, and a trial using oral water-
soluble contrast media to stimulate the bowel and resolve obstruction.3 Yet, a significant 
proportion will need surgery to relieve the obstruction. As a standard, surgery has been 
performed via laparotomy to obtain wide field for safe adhesiolysis. Recently, use of laparoscopy 
has increased in several visceral operations, and even complex elective procedures are nowadays 
being performed.4-6 The feasibility, increase in expertise, and excellent results of these elective 
laparoscopic procedures have led to push the boundaries in emergency laparoscopic surgery.  
 Laparoscopic approach for small bowel obstruction is theoretically controversial. On one 
hand, it is ideal approach, as the adhesion causing the obstruction is often only a single band and 
the objective of the operation is just to cut that band. On the other hand, obstructed small bowel 
is dilated and fragile, and fills the abdominal cavity leaving little room to move instruments making 
the procedure technically demanding. 
 Pooled analyses of non-randomized series suggest significant reductions in mortality, 
morbidity, wound infections, and length of hospital stay by using laparoscopic approach instead of 
open surgery.7-10 It is acknowledged that these series have high risk of bias owing to obvious 
selection of less severe cases to laparoscopic approach.10,11 Although laparoscopic approach is 
used more frequently than before,12,13 it has not gained widespread acceptance. Only 50-60% of 
surgeons would consider using laparoscopy for small bowel obstruction in surveys carried out in 
the UK and Connecticut.14,15 The lack of widespread adoption can be appointed to three major 
reasons: laparoscopic adhesiolysis is technically demanding,3 it has been associated with higher 
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risk of iatrogenic bowel injury, 12 and, to our knowledge, there is no randomised evidence of 
benefit and safety.8,10,11,13 
 Because of controversy regarding the safety and benefits of laparoscopic adhesiolysis over 
open approach for small bowel obstruction, we conducted LAparoscopic versuS open adhesiolysis 
for adhesive Small bowel Obstruction (LASSO) trial. The main hypothesis was that laparoscopic 
adhesiolysis is feasible treatment of adhesive small bowel obstruction, and it shortens the length 
of hospital stay without increasing morbidity. This publication reports primary and secondary 
(short-term) outcomes, while tertiary (long-term) outcomes will be reported when 5-year follow-
up will be available. 
 
Methods 
Study design and participants 
The LASSO trial was an international, multicenter, open-label, parallel group, individually 
randomised superiority trial comparing laparoscopic approach to open surgery in patients with 
acute adhesive small bowel obstruction that was not resolved by conservative means. The trial 
was conducted in five academic university and three community (central) hospitals in two 
countries (Finland and Italy). The trial was registed prior commencement at ClinicalTrials.gov 
(NCT01867528). The full protocol of the trial has been published earlier.16 The trial protocol was 
approved by ethical committee of the Helsinki University Hospital, and also by the institutional 
review boards at each site. 
 Patients with clinical and radiological (computed tomography) signs of acute adhesive 
small bowel obstruction were eligible. As adhesive small bowel obstruction has a high tendency to 
resolve without surgery, patients underwent a trial of conservative therapy prior inclusion in the 
trial: nasogastric tube was inserted, patients were admitted to surgical ward and if no signs of 
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resolving obstruction were present after 12 hours, an oral water-soluble contrast (Gastrografin®) 
was administered. After at least eight hours wait an abdominal x-ray was taken, and if the contrast 
had not advanced to colon, the obstruction was deemed not to resolve by conservative means. If 
Gastrografin® was contraindicated (e.g. allergy) or not available, a 48-hour conservative treatment 
was required to deem conservative means ineffective i.e. there were no signs of bowel function 
and there was significant secretion into the nasogastric tube. 
 Patients who had an anesthesiological contraindication, age below 18 years or over 95 
years, pregnant, living in institutionalized care, and with a hospital stay more than one week prior 
to surgical consultation were excluded from the trial. Patients with suspicion of either 
strangulation or peritonitis were excluded because immediate operative treatment was necessary. 
In addition, patients who had undergone bariatric surgery were excluded as there is a wide 
consensus that these patients should be operated laparoscopically. As the complexity of adhesions 
causing small bowel obstruction are impossible to estimate clinically or radiologically, we 
introduced several exclusion criteria in order to select patients that would have a high likelihood 
of having a single adhesive band causing the obstruction. We hypothesized that by including only 
patients with single adhesive band, and thus technically easy cases for laparoscopic adhesiolysis, 
we could keep the conversion rate to open surgery at minimum. Exclusion criteria are shown in 
patient selection flow chart (Figure 1). All patients gave written informed consent to participate in 
the trial. 
 
Randomisation and masking 
Patients were randomly allocated in a 1:1 ratio to undergo open or laparoscopic adhesiolysis. The 
randomisation sequence was generated using Blockrand 1.1 package with R statistical software (R 
Foundation for Statistical Computing, Vienna, Austria). A block randomisation with randomly 
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varying block size (2, 4, or 6) was stratified according to center. The information regarding block 
size was openly stated in the protocol, but as it was randomly varied, the persons recruiting 
patients were not aware which of the varied block size was used at that particular point of time.  
The randomisation sequence was concealed in an opaque numbered envelopes by a person not 
part of the trial. The recruiters, treating physicians, researchers, and patients were unaware of the 
randomization sequence. Patients were randomised by opening the sealed envelope containing 
the assigned group. As this was an open-label trial, patients, care providers, outcome assessors, 
nor data analyst were not blinded.  
 
Procedures 
Fluid balance and electrolyte distrurbances were corrected preoperatively and prophylactic 
antibiotics (cefuroxime 1500mg and metronidazole 500mg) were administered just before 
incision. Epidural catheter was inserted if deemed necessary by the anesthesiologist.  
 For open surgery, midline incision was used, adhesions were dissected and fascia and skin 
closed. For laparoscopic approach a standardized method was instructed. Small bowel was 
examined starting from terminal ileum with meticulous care taken not to grasp or harm the 
dilated small bowel. To maintain safety, prespecified criteria for conversion to open surgery were 
created: 1) confirmed or suspected small bowel perforation, which is not amenable for 
laparoscopic suturing, 2) a transition site is not identified, 3) the reason for obstruction is not 
found, 4) peritoneal carcinosis is detected, 5) the presence of widespread diffuse adhesions, and 
6) need for bowel resection. All surgeons performing either open or laparoscopic surgery were 
required to have solid experience and skills for complex laparoscopic procedures, and needed to 
have performed at least two laparoscopic adhesiolysis prior operating on patients randomised in 
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the trial. The operating surgeon was the on-call surgeon, or the center’s investigator. These 
qualified surgeons were allowed to perform both open and laparoscopic procedures. 
 Postoperative care was also standardised with following instructions: Nasogastric tube was 
instructed to be kept in place until secretion was less than 500 ml per eight hours. After removal 
of the nasogastric tube, the patient was allowed to drink up to 200 ml per every six hours. 
Thrombosis prophylaxis and proton pump inhibitors were used during the hospital stay. Only 
ibuprofen, paracetamol, tramadol, and oxycodone were used for pain, in addition to possible 
wound or epidural catheter. There was no specific guidance in the study protocol for early 
mobilisation or physiotherapy. 
 Criteria for discharge were prespecified: 1) passage of stools, 2) The patient tolerates per 




Primary outcome of the trial was postoperative length of hospital stay assessed at time of 
discharge. Secondary outcomes were time to passage of stools during hospital stay, time to 
commencement of enteral nutrition during hospital stay, 30-day mortality, complications graded 
by Clavien-Dindo classification within 30 days, number of participants with iatrogenic small bowel 
lesions detected at the operation or within hospital stay, number of participants with 
readmissions within 30 days, number of participants with failure to resolve obstruction during 
hospital stay, pain score on visual analog scale in the first seven postoperative days, length of 
epidural catheter analgesia during hospital stay, total need of opiods during hospital stay, length 
of sick leave assessed at 30-day follow-up or at the end of sick leave, and conversion rate assessed 
during operation. Opioids were converted morphine equivalent doses using conversion factors of 
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0·1 for tramadol and 1·5 for oxycodone. Pain was evaluated using Visual Analog Scale daily, and 
always before administrating pain killers. Length of sick leave was registered in patients who were 
discharged to home, under 65 years, and not pensioned. The length of sick leave was at the 
discretion of surgeon, who took into consideration patient’s age and type of work. Thirty-day 
follow-up was undertaken by a phone call to the patient, and return to work, possible late 
complications, and readmissions were registered. The reported sick leave was based on the actual 
date on which the patient returned to work. The data was gathered prospectively using an 
electronical (Finnish hospitals) or paper case report forms (Italian hospitals). 
 
Statistical analysis 
Based on data derived from earlier retrospective series,17 we aimed to show that the laparoscopic 
approach would shorten the postoperative length of stay by 2·5 days, and estimated the mean 
postoperative length of stay in open group to be 7·25  days (SD 5) and 4·75 days (SD 3·75) in 
laparoscopic group. Sample size calculation was based on two-sided t-test for two independent 
means. We calculated that 102 patients are needed to show this difference with 80% power at 5% 
significance level.  
Continuous outcomes with non-normal distrubution were log-transformed (natural logarithm) to 
obtain normal distribution, and log-transformed outcomes were then compared using t-test. 
Obtained means were then back transformed using anti-log function to obtain geometric means. 
Effect size for such outcomes were reported as ratio of geometric means and its 95% confidence 
interval. Variables that had non-normal distribution and could not be log-transformed into normal 
distribution, were compared using Mann-Whitney-U-test. Effect size for such outcomes was 
reported as r (=Z/√N) without 95% confidence intervals.  Categorical outcomes were compared 
using Fischer’s exact-test (if expected cases in one cell < 5) or Chi-square-test. Effect size for 
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categorical outcomes were reported as odds ratio with 95% confidence intervals.  Statistical 
analyses were performed using SPSS Statistics 24 software (IBM, Armonk, NY). Statistical 
significance was set at a two-sided alpha level of 0·05, without correction for multiple testing. 
Number of cases with missing data is stated either in the manuscript text or tables. Cases with 
missing data were omitted from analyses of that specific variable of interest. All outcomes were 
analyzed using modified intention-to-treat principle, which included all the patients who were 
randomised according to the trial protocol’s inclusion and exclusion criteria, and proceeded to 
surgery (i.e. the obstruction did not resolve while waiting for surgery). There was one change in 
the study protocol in May 2014 : the inclusion criteria originally stated “48-hour conservative 
treatment without Gastrografin is allowed for iodine allergic patients”, and  was changed to “48-
hour conservative treatment without Gastrografin is allowed if Gastrografin is contraindicated 
(e.g. allergy) or not available”. No other changes to the study protocol was made after the 
commencement of the trial. 
 
Role of the funding source 
The funding sources did not have any role, in study design, in the collection, analysis, 
interpretation of data, in the writing of the report, or in the decision to submit the paper for 
publication.  VS and PM had access to the raw data of all patients. The corresponding author had 







One hundred and four patients were enrolled in eight hospitals in Finland and Italy between 18th 
July 2013 and 9th April 2018 (see Appendix p1). The study was ended because calculated sample 
size was achieved.  Details of assessment, exclusion and allocation are shown in Figure 1. One 
hundred patients were included in the modified intention-to-treat analyses. Two patients were 
excluded because the obstruction resolved before surgery, and two patients were excluded 
because they were randomised in spite of exclusion criteria met (Figure 1). The open and 
laparoscopic adhesiolysis groups were highly similar in regard to age, sex, body-mass-index, ASA 
score, comorbidities, duration of symptoms, earlier ileus, earlier abdominal operations, 
nasogastric tube secretion prior surgery (Table 1). Despite rigorous selection of patients with aim 
of a single adhesive band causing obstruction, approximately one third in both groups had more 




97 patients received Gastrografin challenge, while two patients were not administered 
Gastrografin® owing to having conservative therapy over 48 hours and one patient was not 
administered Gastrografin due to allergy. Patients were operated by 23 surgeons. Duration of 
surgery was 46 minutes (interquartile range  [IQR], 31 to 70) in open group and 50 minutes (IQR, 
34 to 70) in laparoscopy group. The total length of operative room stay was 124 minutes (IQR 109 
to 150) in open group and 120 minutes (IQR 105 to 139) in laparoscopy group. Bowel resection 
was performed in 12 patients (24%) in open group and in 2 patients (4%) in laparoscopy group. 
The reasons for bowel resection in open surgery group were irreversible ischemia in six, incidental 
Meckel’s diverticulum in one, adhesive stricture in one, inflammatory stricture in one, cancer in 
two, and full thickness iatrogenic bowel perforation in one patient. The reasons for bowel 
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resection in laparoscopic group were bowel perforation (non-iatrogenic) in one and irreversible 
ischemia in one patient. Surgery in 13 patients (25%) in laparoscopic group were converted to 
open surgery at median 20 minutes (IQR 10 to 40) from the beginning of the surgery. All 
conversions to open surgery were performed through midline incision. The reason for conversion 
was following: unable to find obsructive adhesion in 3 patients, unable to relieve obstructive 
adhesion in one patient, diffuse adhesions in 3 patients, iatrogenic bowel lesion in 3 patients, need 
for bowel resection in 2 patients, and bowel perforation (not iatrogenic) in one patient. Median 
length of laparotomy incision was 12 cm (IQR, 11 to 17, data missing in one patient) in open group, 
and 20 cm (IQR, 13 to 20) in 13 patients in laparoscopy-converted-to-open-surgery group.  
 
Outcomes 
The postoperative length of stay for open group was on average 1·3 days longer than that in 
laparoscopy group (geometric mean 5·5 (range 2 – 19) versus 4·2 (range 1 - 20), ratio of geometric 
means 1·31 (95% confidence interval 1·06 – 1·61), p = 0·013). The total length of hospital stay stay 
for open group was on average 1·5 days longer than that in laparoscopy group (geometric mean 
8·5 (range 5 – 21) versus 7·0 (range 3 - 24), ratio of geometric means 1·21 (95% confidence interval 
1·05 – 1·41), p = 0·009). 
 Time from surgery to bowel function was shorter in laparoscopy group (geometric mean 41 
hours) than in open group (geometric mean 63 hours), but median time to per oral feeding was 
similar between the groups (geometric means 30 hours in laparoscopy group, 35 hours in open 
group) (Table 2). Parenteral nutrition was given in 7 patients (14%) in both groups. Median 
nasogastric tube secretion after surgery was 300 ml [IQR, 100 to 855] in open and 380 ml [IQR, 
100 to 800] laparoscopic group. Obstruction was relieved by first surgery in all patients. One 
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patient in the open group was readmitted due to urinary tract infection and relative ileus. Three 
patients were readmitted in the laparoscopy group due to colitis, ileus, and pneumonia. 
 The rate of complications (21 (43%) vs. 16 (31%), p = 0·23, odds ratio [OR] 0·61 (95% CI 
0·27 – 1·38)), clinically significant complications (Clavien-Dindo grade 2 or higher, 12 (24%) vs. 8 
(16%), p = 0·27, OR 0·57 (0·21 – 1·55)), or in major complications (Clavien-Dindo 3 or higher, 3 (6%) 
vs. 4 (8%), p = 0·74, OR 1·31 (0·28 – 6·16)) was similar between open and laparoscopic groups, 
respectively (Table 3). Surgical site infections were detected in 3 patients (6%) in open group and 
in 3 patients (6%) in laparoscopy group (Table 3). The rate of iatrogenic bowel lesions was similar 
between the groups (Table 2). There were 9 serosal tears and 2 full thickness iatrogenic 
perforations in open group and 8 serosal tears and 4 full thickness iatrogenic perforations in 
laparoscopy group. Only one bowel perforation was unnoticed during primary surgery (in 
laparoscopy group), and this led to peritonitis, and ultimately death of the patient (see next 
paragraph).  
 One patient died within 30 days from randomisation in both open and laparoscopy groups. 
An elder and comorbid patient in the open group did not give consent to operatively relieve small 
bowel obstruction until five days of conservative therapy including Gastrografin challenge was not 
relieving the obstruction. When consent was obtained, the patient was enrolled and operated. 
One adhesive band was released in surgery and no iatrogenic bowel lesion occurred. The patient 
deterioated quickly after surgery and died of multi-organ failure during 1. postoperative day in 
intensive care unit. Another elder and comorbid patient in the laparoscopic group underwent 
laparoscopic adhesiolysis without conversion for local diffuse adhesions (not a single band). No 
bowel lesion was noticed during primary operation. The patient was reoperated for clinical 
peritonitis on third postoperative day via midline laparotomy. A small bowel perforation was 
sutured in the area of adhesiolysis. The patient also had a pneumonia, which was diagnosed prior 
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primary operation. The patient met the prespecified discharge criteria, the overall status was 
improving, the patient was discharged to rehabilitation hospital on 11th postoperative day. The 
patient was readmitted on 14th postoperative day in shock and died in the emergency room. 
Autopsy concluded that the patient died of coronary heart disease, and that the postoperative 
peritonitis had settled, but was a factor in the death along with pneumonia.  
 Pain on visual analog scale was lower in laparoscopy group than open group on 
postoperative days 3 and 4 (Figure 2). Epidural catheter was inserted in 28 patients (57%) in open 
group and in 5 patients (10%) in laparoscopy group (p < 0·0001). Wound analgesia catheters were 
inserted in 3 patients (6%) in open group and in 2 patients (4%) in laparoscopy group. The length 
of epidural catheter was longer in open group (median 39 hours versus median 0 hours) (Table 2). 
Opioid use was similar in both groups (Table 2). 
 The length of sick leave was on average 12 days longer in open group than in laparoscopy 
group (geometric means 24 days versus 12 days) (Table 2). 
 
Discussion 
In this international, multicenter trial, we randomised patients with acute small bowel obstruction 
resistant to non-operative treatment to undergo either open or laparoscopic adhesiolysis. Patients 
randomised to laparoscopic approach had shorter length of hospital stay, quicker return of bowel 
function, less inserted epidural catheters, less postoperative pain, and shorter sick leave. There 
were no differences in complications, bowel injury, or opioid use. 
 Several earlier systematic reviews and meta-analyses of non-randomised series have found 
dramatic drop in morbidity, mortality, wound infections, and length of stay.7-10 As there is no other 
randomised trial, this study provides the best evidence so far for the differences between open 
and laparoscopic approach for small bowel obstruction. Contrary to earlier non-randomised series, 
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our study did not find differences in morbidity, mortality, or wound infections. Length of stay was 
shortened by approximately one day in current trial, while earlier series have reported typically 3- 
to 4-day difference in favor of laparoscopy even in adjusted analyses.12,18 13,17,19-21 It seems clear, 
and also acknowledged before, that less severe cases were selected for laparoscopic approach in 
the earlier series,10,11 and this bias cannot be abolished by statistical means. Along with shorter 
hospital stay, we found quicker return of bowel function (71 hours versus 43 hours) and reduced 
use of epidural catheter (57% vs 10%) in the laparoscopy group. While return of bowel function 
might be of less clinical value, insertion of epidural catheter is an invasive procedure with a risk of 
epidural haematoma around 1:3500.22 One of the feared complication of laparoscopic adhesiolysis 
is iatrogenic bowel injury. A recent publication from Canada reporting over 8000 patients 
undergoing operation for adhesive small bowel obstruction reported increased risk of bowel injury 
in patients undergoing laparoscopic approach compared to open approach (odds ratio 1.6).12 
Some series have reported bowel injury in 6·3 to 26·9% of patients undergoing laparoscopy 
adhesiolysis for small bowel obstruction.17,23-25 The figure in this trial (22%) is comparable to these 
figures, but the rate of bowel injury was similar in open group (22%) also. A possible reason for 
lower rate of iatrogenic bowel injury in earlier non-randomised studies is reporting bias i.e. small 
lesions might not be accurately collected in retrospective data collection. However, unnoticed 
iatrogenic bowel injury present a potential for severe complications, and this occurred in one 
patient with diffuse adhesions in the laparoscopy group, who later died of cardiovascular 
complications after having had a reoperation for peritonitis. We therefore suggest low threshold 
for conversion to open surgery in cases where the obstruction is not caused by a single band. 
 Our trial has several limitations. First, the sample size was relatively small and some 
analyses might suffer from type 2 error (aka false negative results). Although small bowel 
obstruction is relatively common emergency, large proportion is resolved without surgery, and 
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only a portion of the ones needing surgery are suitable for laparoscopic approach. Further, 
laparoscopic adhesiolysis is a demanding procedure, and needed expertise is not always present 
during off-duty hours, especially in lower volume hospitals.3 Further, randomised clinical trials are 
notoriously difficult to carry out in emergency surgery. Current trial enrolled patients in eight 
hospitals in two countries, and it took five years to recruit the target sample size. It is unlikely that 
a larger randomised trial comparing laparoscopy to open surgery for adhesive small bowel 
obstruction will be executed. Second, this trial had strict inclusion and exclusion criteria in order to 
select patients with high likelihood of a single adhesive band causing the obstruction. This is 
reflected by the fact that nearly 600 patients were screened in order to enroll hundred patients. 
Thus the results of the trial are not representative to all patients with adhesive small bowel 
obstruction. However, even in this highly selected population conversion to open surgery occurred 
in 25%, and iatrogenic bowel injury in 22% of the patients. It is likely that these figures would be 
higher had more complex cases been included. On the other hand, our results are highly externally 
valid as the trial was commenced in two countries’ eight hospital, of which three were not 
acadamedic university hospitals, and large pool of surgeons were operating on the patients. 
However, we did not account for surgeons or centers in the analyses of the outcomes. 
Additionally, we had prespecified criteria for discharge, but the protocol did not outline specific 
indications for commencement and cessation of parenteral nutrition. Finally, we report only short-
term results, and laparoscopic approach might have additional benefits in the long-term. Our plan 
is to continue follow-up up to 10 years from randomisation, and next report is scheduled to be 
released after 5-year follow-up has been achieved in all patients. These long-term outcomes will 
include rates of incisional hernias and recurrent small bowel obstruction, which are hypothesized 
to be lower in laparoscopy group. On the other hand, a retrospective series reported increased 
incidence of recurrent small bowel obstruction associated with laparoscopic adhesiolysis.26 
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 In conclusion, our results indicate that laparoscopic adhesiolysis in small bowel obstruction 
results in quicker recovery. The criteria introduced in this trial may be used as a guideline to select 
patients for laparoscopic approach. 
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Figure 1. Enrollment, randomisation, and follow-up. 
Figure 2. Pain during hospital admission. Pain was lower in laparoscopy group on day 3 (median 2 
(IQR 1 – 3) versus median 1 (IQR 0 – 2), p = 0·006, r = 0·32) and day 4 (median 1·5 (IQR 0·5 – 3) 
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Table 1. Demographic and operative characteristics of included patients 
 Open surgery 
(N = 49) 
Laparoscopy 
(N = 51) 
Median age (IQR, range) - yr  74 (60 – 84, 24 - 
94) 
73 (60 – 81, 32 - 93) 
Female sex - no. (%) 31 (63%) 34 (67%) 
Mean Body Mass Index (SD) - kg/m2 23.2 (3.8) 24.8 (4.7) 

















 Open surgery 
(N = 49) 
Laparoscopy 
(N = 51) 
Comorbidities - no. (%) 
 Myocardial infarction 
 Congestitve heart failure 
 Coronary disease (not infarction) 
 Hypertension 
 Peripheral vascular disease 




 Connective tissue disease 
 Liver disease 
 Mild 
 Moderate / Severe 
 Peptic ulcer disease 
 Diabetes mellitus 
 without complications 
 with complications 
 Kidney disease (moderate / severe) 
 Solid tumor 

























































 Open surgery 
(N = 49) 
Laparoscopy 
(N = 51) 
Median duration of symptoms prior admission (IQR) - hours 46 (13 - 72) 48 (23 - 120) 






























Median nasogastric tube secretion before surgery (IQR) - 
ml 
2800 (1000 - 4600) 2700 (1300 - 
3781)### 
Cause of obstruction detected at surgery - no. (%) 
 Single adhesive band 
 Adhesions, more than one band 
 Peritoneal pouch / internal hernia 
 Scarring of bowel wall, no band 
 Intraluminal fecolith 




















 Open surgery 
(N = 49) 
Laparoscopy 
(N = 51) 
Bowel status as detected at surgery - no. (%) 
 Vital 
 Reversible ischemia 










AIDS = acquired immunodeficience syndrome. ASA = The American Society of Anesthesiologists (ASA) physical status 
classification systems. COPD = chronic obstructive pulmonary disease. IQR = interquartile range. No significant 
differences were identified between the treatment groups in any baseline variables, except for “Coronary disease (not 
infarction)” p = 0.049. 
#data missing from 2 patients in open surgery group. 
##Includes also ceasarean sections and laparoscopic procedures. None of the patients had 3 (or more) open 
abdominal operations in history (which would have been exclusion criteria).  
###data missing in one patient  




Table 2. Primary and secondary outcomes 
 Open surgery 
(N = 49) 
Laparoscopy 







   
Primary outcome        
Mean&& length of postoperative 
hospital stay (range) - days 
5·5 (2 – 19)† 4·2 (1 – 20) 0·013 1·31 
(1·06 – 
1·61) 
   
Secondary outcomes        
Mean&& time to bowel function 
(range) - hours 





   
Mean&& time to per oral feeding 
(range) - hours 
35 (13 - 255)# 30 (7 - 163)‡ 0·23 1·18 
(0·90 – 
1·54) 
   
Death at 30 days - no. (%) 1 (2%) 1 (2%) 1 0·96 
(0·06 – 
15·8) 
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 Open surgery 
(N = 49) 
Laparoscopy 







   
Readmission within 30 days, n (%) 1 (2%)† 3 (6%) 0·62 2·94 
(0·30 – 
29·26) 
   
Median length of epidural catheter 
(IQR), hours 
39 (0 - 54) 0 (0 - 0) <0·000
1 
0·51    
Median opioid / day (IQR) ## - mg of 
morphine equivalent€€ 
5.7 (1.0 - 12.0) 
 
3.6 (0 - 12.2) 0·47 0·07    
Mean&& length of sick leave (range) 
- days### 
24 (12 - 65) 
n = 10 
12 (3 - 49) 




   
IQR = interquartile range. SD = standard deviation. 
&&geometric mean 
&&&For geometric means, ratio of geometric means is given with 95% confidence interval. For means, difference of 
means is given with 95% confidence interval. For binary outcomes, odds ratio is given with 95% confidence interval. 
For medians, r = Z/√N is given withouth 95% confidence intervals.  
†available for 48 patients as one patient died during primary hospital stay  
‡missing in 1 patient 
#missing in 2 patients  
##per postoperative day during hospital stay, missing in 2 patients in open surgery arm 
€€Calculated from tramadol and oxycodone usage 




Table 3. Postoperative complications within 30 days 
 Open surgery 
(n = 49) 
Laparosopy 
(n = 51) 




 Superficial wound infection 
 Electrolyte inbalance 
 Urinary retention 
 Diarrhea 
 Diuretics 






















Prolonged ileus with Gastrografin 
Prolonged ileus with parenteral nutrition 
Fever with antibiotics 
Pneumonia 































 Open surgery 
(n = 49) 
Laparosopy 
(n = 51) 
 3b 























 5 (death) 
 Multi-organ failure 







Surgical site infections - no. (%) 
 Any 
 Superficial incisional 
 Deep incisional 
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566 Patients were assessed for eligibility 
462 Were excluded 
♦   180 Did not meet inclusion criteria (48 had no small bowel occlusion in CT, 132 occlusion 
resolved with conservative means) 
♦   239 Had exclusion criteria (some patients had several exclusion criteria) 
 Suspicion of strangulation or peritonitis (n=49) 
 Confirmed/suspected peritoneal carcinosis (n=14) 
 Known wide adhesions (n=27) 
 Previous open surgery for endometriosis (n=9) 
 Previous generalized peritonitis (n=16) 
 Abdominal malignancy (or remission < 10 years) (n=56) 
 Previous radiotherapy of the abdominal region (n=25) 
 Previous obesity surgery (n=2) 
 3 or more earlier open abdominal operations (n=64) 
 Suspicion of other source of obstruction than adhesions (n=25) 
 Recent abdominal operation (within 30 days) (n=23) 
 Previous laparotomy for aorta or iliac vessels (n=7) 
 Crohn’s disease (n=2) 
 Anesthesiological contraindication for laparoscopy (n=6) 
 Patient living in institutionalized care (n=14) 
 Hospital stay more than one week prior to surgical consultation (n=21) 
 Age > 95 years (n=1) 
♦   18 Declined to participate  
♦   25 Had other reason 
 Patient transferred to another hospital for treatment (n=2) 
 On-call surgeon not experienced in laparoscopic adhesiolysis (n=14) 
 Patient not living in Finland, follow-up impossible (n=1) 
 Unable to obtain written consent due not speaking Finnish or Swedish (n=1) 
 Mentally disabled (n=1) 
 Dementia (n=2) 
 On-call surgeon decided to operate (n=3) 
 Treatment restricted to non-operative means due to terminal malignancy (n=1) 
49 Were included in the modified 
intention-to-treat analysis   
 
1 was excluded the analysis owing 
to not receiving intervention 
(outcomes not accessible) 
1 was excluded owing to severe 
protocol violation (randomized in 
spite of exclusion criteria met 
(earlier abdominal malignancy 
and radiotherapy) 
51 Were allocated to open surgery  
 50 Received allocated intervention  
     1 Did not receive allocated intervention 
 owing to resolving obstruction before 
 planned surgery 
53 Were allocated to laparoscopy 
  52 Received allocated intervention 
 1 Did not receive allocated intervention 
owing to resolving obstruction before 
planned surgery 
  
104 Patients underwent randomization  
1 was excluded the analysis owing 
to not receiving intervention 
(outcomes not accessible) 
1 was excluded owing to severe 
protocol violation (randomized in 
spite of exclusion criteria met 
(earlier abdominal malignancy) 
51 Were included in the modified 
intention-to-treat analysis   
 

